Key result
Endogenous 17β-oestradiol is linked to higher plasma fibrinogen in postmenopausal women, especially overweight subjects.
Why the study?
Are endogenous sex steroid hormones associated with plasma fibrinogen levels in postmenopausal women?
Cohort (n=602)
Yes
Are endogenous sex steroid hormones associated with plasma fibrinogen levels in postmenopausal women?
Endogenous oestradiol is positively and independently correlated with plasma fibrinogen in postmenopausal women, suggesting a potential deleterious effect on cardiovascular risk profile.
Answers are grounded in this paper and cite their sources.
May link endogenous oestradiol to fibrinogen-related cardiovascular risk in postmenopausal women; hypothesis-generating and requires prospective validation.
BACKGROUND: Plasma fibrinogen is a strong predictor of ischaemic arterial disease in women. Sex steroid hormones including hormone therapy may play an important role in the development of cardiovascular disease. However, whether endogenous sex steroid hormones influence the plasma fibrinogen concentrations among postmenopausal women remains unclear. OBJECTIVES: To investigate the association of plasma fibrinogen levels with endogenous sex steroid hormones and sex hormone binding globulin (SHBG) among postmenopausal women. METHODS: We used data from the French prospective Three-City cohort study that included 9294 noninstitutionalized men and women over 65 years of age. Total 17β-oestradiol (E2, pg/ml), total testosterone (T, ng/ml), SHBG (nm) and fibrinogen (g/l) were measured in stored plasmas in a subcohort of 602 randomly selected postmenopausal women who used neither hormone medication nor anticoagulation therapy. Multivariate linear regression models were used to estimate the regression coefficients assessed in fibrinogen unit by 1 SD increase in log-distribution of sex steroid hormones and SHBG. RESULTS: E2 but neither T nor SHBG was positively associated with plasma fibrinogen levels (β = 0·148, P < 0·001). Adjustment for cardiovascular risk factors including diabetes made no substantial change to the results (β = 0·145, P < 0·001). The association of fibrinogen with E2 was stronger among women with body mass index over 25 kg/m(2) compared with those with normal weight (β = 0·156, P < 0·001 and β = 0·092, P = 0·02, respectively, P for interaction = 0·04). CONCLUSION: E2 emerges as a positive and independent correlate of plasma fibrinogen among postmenopausal women, especially in subjects who are overweight. These findings suggest a deleterious effect of endogenous oestrogens on cardiovascular risk profile among postmenopausal women.
No takes yet. Share an insight, caveat, or question.
Canonico et al. (2012) conducted a cohort in Postmenopausal women (n=602). Endogenous 17β-oestradiol (E2) was evaluated on Plasma fibrinogen levels (β = 0.148, p=<0.001). Endogenous 17β-oestradiol was positively associated with plasma fibrinogen levels among postmenopausal women, with a stronger association in overweight subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: